Kobayashi Yuka, Sugitani Soichi, Oseki Koshi, Iiri Takao
Department of Gastroenterology, Tachikawa General Hospital.
Nihon Shokakibyo Gakkai Zasshi. 2011 Oct;108(10):1696-704.
A 71-year-old man was admitted to our hospital in September 2009 because of severe headache due to meningeal carcinomatosis. In July 2007, subtotal gastrectomy was carried out for gastric cancer. Because intraabdominal cytodiagnosis was positive, he received systemic chemotherapy for 2 years. Recurrent signs were not found on chest or abdominal CT just before hospitalization. He was given NSAIDs and corticosteroid, but his symptom did not improve. Subsequent intrathecal chemotherapy with MTX and Ara-C improved clinical symptoms dramatically. He received care at home for 3 months before he passed away due to pleural and peritoneal recurrence. Recently, since the frequency of meningeal carcinomatosis is increasing, combination treatment of intrathecal chemotherapy and systemic chemotherapy should be considered not only for improvement of clinical manifestations, but also for prognostic improvement.
一名71岁男性因脑膜癌病导致的严重头痛于2009年9月入住我院。2007年7月,因胃癌行胃大部切除术。由于腹腔内细胞诊断呈阳性,他接受了2年的全身化疗。住院前胸部或腹部CT未发现复发迹象。给予他非甾体抗炎药和皮质类固醇,但症状未改善。随后鞘内注射甲氨蝶呤和阿糖胞苷化疗使临床症状显著改善。他在家中接受了3个月的护理,之后因胸膜和腹膜复发去世。最近,由于脑膜癌病的发病率在增加,应考虑鞘内化疗和全身化疗联合治疗,不仅为了改善临床表现,也为了改善预后。